CRIS Research and Charts

CRIS - Curis Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-05 (Delayed quote data 2025-05-09)

Last 1.89	Change ⇓ -0.21 (-10.00%)	Volume 80,161
	Open 2.12	High 2.25	Low 1.85

8EMA (Daily) 2.06	40EMA (Daily) 2.04	50EMA (Daily) 2.14	STO (Daily) 60.879	MACD Hist (Daily) 0.097
8EMA (Weekly) 1.999	40EMA (Weekly) 4.03	50EMA (Weekly) 4.80	STO (Weekly) 25.622	MACD Hist (Weekly) 0.140


Company Profile
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.